© Drug Hunter Inc. 2018-2023
Home > LMB763 (nidufexor)
selective FXR partial agonist
orally efficacious in NASH models
from two 3M compound HTS and LBD
J. Med. Chem., Jan. 15, 2020
Novartis (GNF), San Diego, CA
LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year